Published in Br Med J on September 27, 1980
Molecular mimicry in pauci-immune focal necrotizing glomerulonephritis. Nat Med (2008) 3.87
Wegener's granulomatosis autoantibodies identify a novel diisopropylfluorophosphate-binding protein in the lysosomes of normal human neutrophils. J Clin Invest (1989) 3.34
The current status of neutrophil cytoplasmic antibodies. Clin Exp Immunol (1989) 1.78
Aggravation of anti-myeloperoxidase antibody-induced glomerulonephritis by bacterial lipopolysaccharide: role of tumor necrosis factor-alpha. Am J Pathol (2005) 1.65
Antimyeloperoxidase-associated proliferative glomerulonephritis: an animal model. J Exp Med (1993) 1.63
Two sisters with ANCA positive vasculitis. Ann Rheum Dis (1993) 1.40
Ocular changes in limited forms of Wegener's granulomatosis. Br J Ophthalmol (1981) 1.39
Monocyte activation in patients with Wegener's granulomatosis. Ann Rheum Dis (1999) 1.31
Anti-neutrophil cytoplasmic autoantibodies in patients with symptomatic HIV infection. Clin Exp Immunol (1992) 1.29
Role of neutrophils in the pathogenesis of experimental vasculitis. Am J Pathol (1996) 1.23
Staphylococcus aureus and Wegener's granulomatosis. Arthritis Res (2001) 1.13
Anti-neutrophil cytoplasm antibodies in rheumatoid arthritis. Clin Exp Immunol (1991) 1.13
Regulatory role of OX22high T cells in mercury-induced autoimmunity in the brown Norway rat. J Exp Med (1993) 1.01
Value of anti-infective chemoprophylaxis in primary systemic vasculitis: what is the evidence? Arthritis Res Ther (2009) 0.99
Anti-proteinase 3 antibodies, their characterization and disease associations. Clin Exp Immunol (1994) 0.97
Passive immunization against tumour necrosis factor-alpha (TNF-alpha) and IL-1 beta protects from LPS enhancing glomerular injury in nephrotoxic nephritis in rats. Clin Exp Immunol (1992) 0.97
Detection of immune deposits in skin lesions of patients with Wegener's granulomatosis. Ann Rheum Dis (2001) 0.96
Management of ANCA-associated vasculitis: Current trends and future prospects. Ther Clin Risk Manag (2010) 0.93
[Classification of ocular surface disease. Part 1]. Ophthalmologe (2003) 0.92
Activation of glomerular mesangial cells by gram-negative bacterial cell wall components. Am J Pathol (1988) 0.92
Pulmonary vasculitis. Thorax (1998) 0.90
Staphylococcal acid phosphatase binds to endothelial cells via charge interaction; a pathogenic role in Wegener's granulomatosis? Clin Exp Immunol (2000) 0.86
Chronic bronchial suppuration and antineutrophil cytoplasmic antibody (ANCA) positive systemic vasculitis. Postgrad Med J (1990) 0.86
Immunization with anti-neutrophil cytoplasmic antibody (ANCA) induces the production of mouse ANCA and perivascular lymphocyte infiltration. Clin Exp Immunol (1995) 0.85
Detection of anti-myeloperoxidase and anti-elastase antibodies in vasculitides and infections. Clin Exp Immunol (1991) 0.83
Studies of epitope restriction on myeloperoxidase (MPO), an important antigen in systemic vasculitis. Clin Exp Immunol (1997) 0.82
The role of cellular immunity in systemic vasculitis. Clin Exp Immunol (1995) 0.81
Th17 expansion in granulomatosis with polyangiitis (Wegener's): the role of disease activity, immune regulation and therapy. Arthritis Res Ther (2012) 0.81
Use of methyl prednisolone and antioxidants in mercuric chloride-induced experimental vasculitis. Clin Exp Immunol (1994) 0.80
Treatment of vasculitis. Br J Clin Pharmacol (1993) 0.80
Nocardia asteroides infection of the cauda equina. J Neurol Neurosurg Psychiatry (1988) 0.79
Relapse of idiopathic pulmonary haemorrhage and glomerulonephritis associated with cytomegalovirus (CMV) infection. Postgrad Med J (1988) 0.78
CD14 expression is increased on monocytes in patients with anti-neutrophil cytoplasm antibody (ANCA)-associated vasculitis and correlates with the expression of ANCA autoantigens. Clin Exp Immunol (2015) 0.77
Pathogenesis and treatment of ANCA-associated systemic vasculitis. J R Soc Med (1999) 0.75
Wegener's granulomatosis. J R Soc Med (1982) 0.75
Idiotypic network, pathogenic autoantibodies and autoimmunity. Clin Exp Immunol (1995) 0.75
Infection in immunologically-mediated diseases: a review. J R Soc Med (1983) 0.75
Pathogenesis of ANCA-associated vasculitis. Rheum Dis Clin North Am (2010) 0.75
Kinetics of glomerular neutrophil influx after lipopolysaccharide in antibody-mediated injury. Clin Exp Immunol (1988) 0.75
Antineutrophil cytoplasmic antibodies (ANCA) and vasculitis. Clin Rheumatol (1990) 0.75
The spectrum of vasculitis: clinical, pathologic, immunologic and therapeutic considerations. Ann Intern Med (1978) 7.17
Defective reticuloendothelial system Fc-receptor function in systemic lupus erythematosus. N Engl J Med (1979) 4.52
Reversal of impaired splenic function in patients with nephritis or vasculitis (or both) by plasma exchange. N Engl J Med (1979) 3.02
Value of immune-complex assays in diagnosis and management. Lancet (1978) 2.39
Enhanced allergic tissue injury in Goodpasture's syndrome by intercurrent bacterial infection. Br Med J (1977) 1.92
Viral infection and renal transplant rejection. Br Med J (1972) 1.87
Viral syndromes and renal homograft rejection. Ann Surg (1972) 1.74
Detection of intrapulmonary hemorrhage with carbon monoxide uptake. Application in goodpasture's syndrome. N Engl J Med (1976) 1.60
Role of virus infections in immunosuppressed renal transplant patients. Transplant Proc (1973) 1.23
Association between Streptococcus faecalis urinary infections and graft rejection in kidney transplantation. Lancet (1978) 0.97
Streptococcal infection as a cause of hyperacute renal allograft rejection. Transplant Proc (1978) 0.93
Equivalence of the mediation, confounding and suppression effect. Prev Sci (2000) 13.92
2012 revised International Chapel Hill Consensus Conference Nomenclature of Vasculitides. Arthritis Rheum (2013) 11.18
Changing disease patterns in patients with AIDS in a referral centre in the United Kingdom: the changing face of AIDS. BMJ (1991) 4.67
Prospective study of radioimmunoassay for antibodies against neutrophil cytoplasm in diagnosis of systemic vasculitis. Lancet (1987) 4.20
AIDS--an immunologic reevaluation. N Engl J Med (1984) 3.53
Reversal of impaired splenic function in patients with nephritis or vasculitis (or both) by plasma exchange. N Engl J Med (1979) 3.02
Immunosuppression and plasma-exchange in the treatment of Goodpasture's syndrome. Lancet (1976) 3.00
Association of alkaline phosphatase with an autoantigen recognised by circulating anti-neutrophil antibodies in systemic vasculitis. Lancet (1987) 2.85
Metabolic studies of the third component of complement and the glycine-rich beta glycoprotein in patients with hypocomplementemia. J Clin Invest (1974) 2.81
HTLV-III/LAV viral antigens in lymph nodes of homosexual men with persistent generalized lymphadenopathy and AIDS. Am J Pathol (1986) 2.77
Inhibition of immune precipitation by complement. Clin Exp Immunol (1980) 2.72
Long-term outcome of anti-glomerular basement membrane antibody disease treated with plasma exchange and immunosuppression. Ann Intern Med (2001) 2.72
The intermediate endpoint effect in logistic and probit regression. Clin Trials (2007) 2.67
The role of complement and its receptor in the elimination of immune complexes. N Engl J Med (1986) 2.63
Complement studies in membrano-proliferative glomerulonephritis. Clin Exp Immunol (1972) 2.60
Dendritic cell infection, depletion and dysfunction in HIV-infected individuals. Immunology (1990) 2.58
HTLV-III: should testing ever be routine? Br Med J (Clin Res Ed) (1986) 2.51
Microscopic polyarteritis: presentation, pathology and prognosis. Q J Med (1985) 2.46
Studies of cellular immunity in male homosexuals in London. Lancet (1983) 2.41
The complement abnormalities of lipodystrophy. N Engl J Med (1976) 2.40
Value of immune-complex assays in diagnosis and management. Lancet (1978) 2.39
Human immunodeficiency virus infection in two cohorts of homosexual men: neutralising sera and association of anti-gag antibody with prognosis. Lancet (1987) 2.34
Safety and activity of saquinavir in HIV infection. Lancet (1995) 2.32
Remission of myasthenia gravis following plasma-exchange. Lancet (1976) 2.25
Complement-mediated inhibition of immune precipitation. I. Role of the classical and alternative pathways. Clin Exp Immunol (1982) 2.20
Immunocytochemical detection of T and B cell populations in routine blood smears. Lancet (1984) 2.17
The effect of defibrination on nephrotoxic serum nephritis in rabbits. Clin Sci (1972) 2.11
Defective reticuloendothelial system function in rheumatoid arthritis. Lancet (1979) 2.10
Glomerular deposition of properdin in Henoch-Schönlein syndrome and idiopathic focal nephritis. Br Med J (1973) 2.07
Wegener's granulomatosis: observations on 18 patients with severe renal disease. Q J Med (1983) 2.07
Soluble forms of vascular adhesion molecules, E-selectin, ICAM-1, and VCAM-1: pathological significance. Ann N Y Acad Sci (1992) 2.06
Three-year prospective study of HTLV-III/LAV infection in homosexual men. Lancet (1986) 2.04
Mesangiocapillary nephritis, partial lipodystrophy, and hypocomplementaemia. Lancet (1973) 2.00
Mycobacterial infection in patients infected with the human immunodeficiency virus. Thorax (1990) 1.95
Role of C3b in the breakdown of C3 in hypocomplementaemic mesangiocapillary glomerulonephritis. Lancet (1973) 1.93
Enhanced allergic tissue injury in Goodpasture's syndrome by intercurrent bacterial infection. Br Med J (1977) 1.92
Prognosis after immunosuppression of patients with crescentic nephritis requiring dialysis. Lancet (1983) 1.87
The neuropil of the glomeruli of the olfactory bulb. J Cell Sci (1971) 1.79
Autoantibodies against bactericidal/permeability-increasing protein in patients with cystic fibrosis. QJM (1996) 1.78
Factors affecting seropositivity to human T cell lymphotropic virus type III (HTLV-III) or lymphadenopathy associated virus (LAV) and progression of disease in sexual partners of patients with AIDS. Genitourin Med (1986) 1.77
Treatment of systemic vasculitis with pooled intravenous immunoglobulin. Lancet (1991) 1.76
The role of polymorphonuclear leucocytes in the autologous phase of nephrotoxic nephritis. Clin Exp Immunol (1975) 1.75
Oxygen-15 brain scanning for detection of cerebral involvement in systemic lupus erythematosus. Lancet (1978) 1.75
Ineffectiveness of AL721 in HIV disease. Lancet (1990) 1.73
Cigarette smoking and lung haemorrhage in glomerulonephritis caused by autoantibodies to glomerular basement membrane. Lancet (1983) 1.72
Function of circulating antibody to acetylcholine receptor in myasthenia gravis: investigation by plasma exchange. Neurology (1978) 1.71
Plasma-exchange and immunosuppression in the treatment of fulminating immune-complex crescentic nephritis. Lancet (1977) 1.71
High incidence of end-stage renal disease in Indo-Asians in the UK. QJM (1995) 1.68
Role of fibreoptic bronchoscopy in management of pneumonia in acquired immune deficiency syndrome. Br Med J (Clin Res Ed) (1985) 1.68
Clinical testing of olfaction reassessed. Brain (1977) 1.68
Studies of serum complement in the hypocomplementaemic nephritides. Clin Exp Immunol (1974) 1.67
Antiglomerular basement membrane antibody mediated disease in the British Isles 1980-4. Br Med J (Clin Res Ed) (1986) 1.65
An immunohistological approach to persistent lymphadenopathy and its relevance to AIDS. Clin Exp Immunol (1985) 1.64
The acquired immune deficiency syndrome. Clin Exp Immunol (1984) 1.62
Visceral leishmaniasis in HIV infection and AIDS: clinical features and response to therapy. Q J Med (1990) 1.61
A quantitative evaluation of anticoagulants in experimental nephrotoxic nephritis. Clin Exp Immunol (1975) 1.61
Helicobacter pylori and HIV infection. Lancet (1990) 1.59
Changing disease patterns in AIDS. BMJ (1991) 1.59
Initial cytokine exposure determines function of macrophages and renders them unresponsive to other cytokines. J Immunol (1998) 1.57
Amyloid P-component is a constituent of normal human glomerular basement membrane. J Exp Med (1980) 1.57
Effect of anti-neutrophil cytoplasm autoantibodies on the intracellular calcium concentration of human neutrophils. Lab Invest (1994) 1.56
Lung function abnormalities in patients infected with the human immunodeficiency virus with and without overt pneumonitis. Thorax (1988) 1.56
Autoantibodies to GBM and neutrophil cytoplasm in rapidly progressive glomerulonephritis. Kidney Int (1990) 1.55
Anti-glomerular basement membrane disease. J Am Soc Nephrol (1999) 1.54
The neuron types of the glomerular layer of the olfactory bulb. J Cell Sci (1971) 1.52
The role of C3 in the autologous phase of nephrotoxic nephritis. Clin Exp Immunol (1976) 1.51
Managing HIV disease after Delta. BMJ (1996) 1.49
Tolerability and side-effects of post-exposure prophylaxis for HIV infection. Lancet (2000) 1.49
Pulmonary function in human immunodeficiency virus infection. A prospective 18-month study of serial lung function in 474 patients. Am Rev Respir Dis (1992) 1.49
The skin and immunosuppression. Australas J Dermatol (1976) 1.48
Complement, the immune-complex lattice, and the pathophysiology of complement-deficiency syndromes. Lancet (1983) 1.48
The immunogloblin nature of nephritic factor (NeF). Clin Exp Immunol (1978) 1.47
Jejunal enteropathy associated with human immunodeficiency virus infection: quantitative histology. J Clin Pathol (1989) 1.47
Albumin metabolism in chronic renal failure. Clin Sci (1970) 1.46
Modulation of antibody-mediated glomerular injury in vivo by bacterial lipopolysaccharide, tumor necrosis factor, and IL-1. J Immunol (1989) 1.44
Intravenous immunoglobulin for ANCA-associated systemic vasculitis with persistent disease activity. QJM (2000) 1.44
Prostacyclin deficiency in haemolytic-uraemic syndrome. Br Med J (1980) 1.43
Kaposi's sarcoma in HIV infection treated with vincristine and bleomycin. AIDS (1992) 1.43
Vascular damage in Wegener's granulomatosis and microscopic polyarteritis: presence of anti-endothelial cell antibodies and their relation to anti-neutrophil cytoplasm antibodies. Clin Exp Immunol (1991) 1.42